AU2002337663A1 - Methods of determining the effects of toxins - Google Patents

Methods of determining the effects of toxins

Info

Publication number
AU2002337663A1
AU2002337663A1 AU2002337663A AU2002337663A AU2002337663A1 AU 2002337663 A1 AU2002337663 A1 AU 2002337663A1 AU 2002337663 A AU2002337663 A AU 2002337663A AU 2002337663 A AU2002337663 A AU 2002337663A AU 2002337663 A1 AU2002337663 A1 AU 2002337663A1
Authority
AU
Australia
Prior art keywords
toxins
determining
effects
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337663A
Inventor
Edward Chow
James M. Holland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2002337663A1 publication Critical patent/AU2002337663A1/en
Abandoned legal-status Critical Current

Links

AU2002337663A 2001-08-03 2002-08-02 Methods of determining the effects of toxins Abandoned AU2002337663A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/309,988 2001-08-03
US10/208,165 2002-07-29

Publications (1)

Publication Number Publication Date
AU2002337663A1 true AU2002337663A1 (en) 2003-03-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2002366827A1 (en) Peer-based location determination
AU2002360508A1 (en) Substituted hydroxyethylamines
AU2002365649A1 (en) Anti-dota antibody
AU2001297856A1 (en) Method for determining homeostasis of the skin
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2002343312A1 (en) Two fixed-beams tx-diversity
AU2002359694A1 (en) Compounds and methods
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2002335667A1 (en) Modified reoviral therapy
AUPR963401A0 (en) Methods for the enhancement of complex peaks
AU2001100347A4 (en) IFCS firewatch
AU2002337663A1 (en) Methods of determining the effects of toxins
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001100406A4 (en) DriverSMS
AU2002357873A1 (en) Carbohydrate-associated proteins
AU2002326909A1 (en) Neurotransmission-associated proteins
AU2002256786A1 (en) Methods
AU2002253381A1 (en) Methods
AU2002300897A1 (en) Slabber Grabber
AUPR722801A0 (en) Slabber grabber
AU2002254470A1 (en) Compounds and methods
AU2002245725A1 (en) Compounds and methods
AU2002247441A1 (en) Compounds and methods